Sleep Problems Latest News
- Older News
-
Report Reveals Patterns of Potentially Unsafe Use of Zolpidem
Psychiatric News (2 days ago) - Despite FDA recommendations that the hypnotic zolpidem be used for short-term treatment of insomnia, most patients report sustained use, according to a report published today in JAMA Internal Medicine. The... -
Mantram Therapy Found to Benefit Veterans With PTSD
Psychiatric News (Monday, 25 June) - A mindfulness-based therapy in which individuals learn to repeat personalized mantras to relax their thoughts appears to be more effective at reducing posttraumatic stress disorder (PTSD) symptoms than a problem-solving... -
Comorbid Medical Conditions May Point to Patients Most Likely to Develop Treatment-Resistant Depression
Psychiatric News (Wednesday, 30 May) - It is well known that some patients with depression will fail to respond to medications, but clinicians currently have few ways to predict those most likely to develop treatment-resistant depression... -
FDA Approves Latuda for Treatment of Youth With Bipolar Depression
Psychiatric News (Thursday, 8 March) - The Food and Drug Administration (FDA) has approved Latuda (lurasidone HCl) for the treatment of depressive episode associated with bipolar I disorder (bipolar depression) in youth ages 10 to 17.Latuda... -
APA Releases New Practice Guideline on AUD Pharmacotherapy
Psychiatric News (Friday, 5 January, 2018) - APA today released a new practice guideline for the pharmacological treatment of alcohol use disorder (AUD). Despite the high prevalence of AUD and its significant public health consequences, patients with... -
FDA Expands Indication of Electric Stimulation Device to Treat Opioid Withdrawal Symptoms
Psychiatric News (Friday, 17 November, 2017) - The Food and Drug Administration (FDA) has approved the use of an electric stimulation device to help to reduce the symptoms of opioid withdrawal, marking the first time a device... -
Insomnia Symptoms, Sleep Medications Increase Risk of Falls in Seniors
Psychiatric News (Thursday, 12 October, 2017) - The more insomnia symptoms an older adult reports, the greater their risk of future falls, according to a study published in the journal Sleep. This risk appears to be even... -
FDA Approves Deutetrabenazine for Treatment of Tardive Dyskinesia
Psychiatric News (Thursday, 31 August, 2017) - Teva Pharmaceuticals Ltd. on Wednesday announced that the Food and Drug Administration has approved Austedo (deutetrabenazine) tablets for the treatment of adults with tardive dyskinesia (TD). Deutetrabenazine is a small...
- next >

